Crystal structures of Leptospira interrogans FAD-containing ferredoxin-NADP+ reductase and its complex with NADP+


Autoria(s): Nascimento, Alessandro S; Catalano-Dupuy, Daniela L; Bernardes, Amanda ; Oliveira Neto, Mario de; Santos, Maria Auxiliadora M; Ceccarelli, Eduardo A; Polikarpov, Igor 
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

26/08/2013

26/08/2013

2007

Resumo

Abstract Background Ferredoxin-NADP(H) reductases (FNRs) are flavoenzymes that catalyze the electron transfer between NADP(H) and the proteins ferredoxin or flavodoxin. A number of structural features distinguish plant and bacterial FNRs, one of which is the mode of the cofactor FAD binding. Leptospira interrogans is a spirochaete parasitic bacterium capable of infecting humans and mammals in general. Leptospira interrogans FNR (LepFNR) displays low sequence identity with plant (34% with Zea mays) and bacterial (31% with Escherichia coli) FNRs. However, LepFNR contains all consensus sequences that define the plastidic class FNRs. Results The crystal structures of the FAD-containing LepFNR and the complex of the enzyme with NADP+, were solved and compared to known FNRs. The comparison reveals significant structural similarities of the enzyme with the plastidic type FNRs and differences with the bacterial enzymes. Our small angle X-ray scattering experiments show that LepFNR is a monomeric enzyme. Moreover, our biochemical data demonstrate that the LepFNR has an enzymatic activity similar to those reported for the plastidic enzymes and that is significantly different from bacterial flavoenzymes, which display lower turnover rates. Conclusion LepFNR is the first plastidic type FNR found in bacteria and, despite of its low sequence similarity with plastidic FNRs still displays high catalytic turnover rates. The typical structural and biochemical characteristics of plant FNRs unveiled for LepFNR support a notion of a putative lateral gene transfer which presumably offers Leptospira interrogans evolutionary advantages. The wealth of structural information about LepFNR provides a molecular basis for advanced drugs developments against leptospirosis.

The authors thank to L. Bleicher and N. Leite for the helpful discussion and to T. Ferrarezi for the help in crystallization trials. We also thank to Fundação de Apoio à Pesquisa do Estado de São Paulo (FAPESP) for the financial support via grant #04/08070-9 and #06/00182-8, to Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and, grants #10777 from CONICET and #01-14650 from Agencia de Promoción Científica y Tecnológica (ANPCyT), Argentina, and the Regional Research Training Fellowships Program of AMSUD/Pasteur.

The authors thank to L. Bleicher and N. Leite for the helpful discussion and to T. Ferrarezi for the help in crystallization trials. We also thank to Fundação de Apoio à Pesquisa do Estado de São Paulo (FAPESP) for the financial support via grant #04/080709 and #06/001828, to Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and, grants #10777 from CONICET and #0114650 from Agencia de Promoción Científica y Tecnológica (ANPCyT), Argentina, and the Regional Research Training Fellowships Program of AMSUD/Pasteur.

Identificador

1472-6807

http://www.producao.usp.br/handle/BDPI/32915

10.1186/1472-6807-7-69

http://www.biomedcentral.com/1472-6807/7/69

Idioma(s)

eng

Relação

BMC Structural Biology

Direitos

openAccess

Nascimento et al; licensee BioMed Central Ltd. - This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Tipo

article

original article